An appeals court has dashed the hopes of three group members of a resolved class action over managed investment schemes operated by agribusiness Great Southern Group who sought more time to appeal approval of the settlement deed, which put them on the hook for repaying their loans to Bendigo and Adelaide Bank.
The Construction, Forestry, Maritime, Mining and Energy union is seeking court approval to intervene in a class action against labour hire company WorkPac on behalf of casual miners who claim they were denied annual leave and other entitlements.
Global engineering firm CIMIC Group has been hit with costs after a last-minute subpoena of three new potential witnesses caused the three-week trial that was due to commence later this month to be vacated.
Mining firm Mach Energy is facing legal action from its former managing director over $20 million in shares allegedly owed under an equity incentive scheme.
A judge who hit Pitcher Partners with a $5.6 million damages ruling over an accounting error concealed from corporate client Neville’s Bus Service was wrong to hold that the transport operator’s losses flowing from the error were real, the firm has argued.
A former Qantas flight attendant who was sacked after getting drunk on peach martinis at a bar while off duty in Manhattan has lost an appeal of a finding that the airline had valid reasons for dismissing him.
The trial in a much anticipated shareholder class action against engineering firm WorleyParsons scheduled to commence this week has hit a roadblock, with a last minute change in the judge that will hear the matter.
An appeals court has overturned a ruling awarding $2 million in compensation to United Petroleum after the state government compulsorily acquired land on which the petrol retailer operated a service station and restaurant.
The ABC paid ousted managing managing director Michelle Guthrie $730,000 to settle a lawsuit alleging unfair dismissal.
Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.